✦ LIBER ✦

2,3-Butanedione monoxime (BDM) as a myosin inhibitor

✍ Scribed by E. Michael Ostap

Book ID: 110413719
Publisher: Springer Netherlands
Year: 2002
Tongue: English
Weight: 113 KB
Volume: 23
Category: Article
ISSN: 0142-4319
DOI: 10.1023/a:1022047102064

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardioprotective effects of 2, 3 butaned

Cardioprotective effects of 2, 3 butanedione 2-monoxime (BDM)

✍ G. Bauza; N. Khandoudi; L. Le Moyec; A.C. Guo; D. Feuvray; M. Eugene 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Does 2,3-butanedione monoxime inhibit no

Does 2,3-butanedione monoxime inhibit nonmuscle myosin?

✍ Arthur Forer; Lacramioara Fabian 📂 Article 📅 2005 🏛 Springer Vienna 🌐 English ⚖ 107 KB

BDM (2,3-butanedione monoxime), an inhib

BDM (2,3-butanedione monoxime), an inhibitor of myosin-actin interaction, suppresses myofibrillogenesis in skeletal muscle cells in culture

✍ Y. Soeno; Y. Shimada; T. Obinata 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 734 KB

2,3-butanedione monoxime (BDM) and contr

2,3-butanedione monoxime (BDM) and contracture in rat ventricle myocytes

✍ Ashley Allshire; Adrian Whitfield; Robert Horton; Peter Cobbold 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 114 KB

EFFECTS OF THE MYOSIN INHIBITOR 2,3-BUTA

EFFECTS OF THE MYOSIN INHIBITOR 2,3-BUTANEDIONE MONOXIME (BDM) ON CELL SHAPE, LOCOMOTION AND FLUID PINOCYTOSIS IN HUMAN POLYMORPHONUCLEAR LEUCOCYTES

✍ N. Urwyler; P. Eggli; H.U. Keller 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 696 KB

## Abstract We investigated the role of myosin in polymorphonuclear leucocyte (PMN) shape changes, locomotion, and fluid pinocytosis using the myosin inhibitor 2,3 butanedione monoxime (BDM). Treatment of resting spherical PMNs with BDM produced spheroid cells showing small continuous shape changes

The myosin ATPase inhibitor 2,3-butanedi

The myosin ATPase inhibitor 2,3-butanedione-2-monoxime (BDM) inhibits tip growth and cytokinesis in the fission yeast,Schizosaccharomyces pombe

✍ May, Karen M. ;Wheatley, Sally P. ;Amin, Vasanti ;Hyams, Jeremy S. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

The growth of fission yeast cultures was reversibly inhibited by exposure to the myosin-ATPase inhibitor 2,3-butanedione-2-monoxime (BDM). Wild-type cells treated with 20 mM BDM for approximately two generation times were smaller than untreated controls and had a septation index approximately twice